After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Have you or someone you love been diagnosed with Alzheimer’s disease? This clinical trial may be just what you.

Ambroxol, long used for coughs in Europe, stabilized symptoms and brain-damage markers in Parkinson’s dementia patients over ...

Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

One of the fundamental barriers to equitable neurological care is the historic male bias in clinical research. For decades, ...

Two new studies have provided further insights into the complex links between head injury in elite rugby and potential ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

After witnessing my mum's cognitive decline and with dementia now the leading cause of death for Australian women, I can't ...

Published today in the prestigious JAMA Neurology, this 12-month clinical trial involving 55 participants with Parkinson's disease dementia (PDD) monitored memory, psychiatric symptoms and GFAP, a ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

Digging into a prespecified analysis for the mid-stage study, INmune Bio identified some clinical and biological benefits of ...

Alzheimer’s Pipeline Report, released by the Kirk Kerkorian School of Medicine at UNLV, reveals dozens of promising drug ...